Literature DB >> 24342136

Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer.

I Cho1, J Y An1, I G Kwon1, Y Y Choi1, J H Cheong1, W J Hyung1, S H Noh2.   

Abstract

AIMS: We carried out a large scale study to identify the risk factors for double primary malignancy (DPM) development in gastric cancer patients and to evaluate the clinical implications for these patients.
METHODS: A total of 2593 patients who underwent gastrectomy for primary gastric cancer from January 2005 to November 2010 were reviewed with regard to DPM. We compared the clinicopathological characteristics, risk factors for developing DPM, and prognosis between the DPM+ group and the DPM- group.
RESULTS: Of the 2593 patients, 152 (5.9%) were diagnosed with DPM. The most common accompanying malignancies were colorectal, lung and thyroid. Multivariate analysis indicated that age (p = 0.016) and MSI status (p = 0.002) were associated with a higher frequency of DPM. 30.3% of patients were diagnosed with DPM within 1 year around perioperative period and 53.3% of patients had DPM detected during 5 years of post-operative follow up periods. Although there was no significant difference in overall survival between the DPM+ and DPM- group, DPM+ patients had a worse prognosis than DPM- patients in stage I gastric cancer.
CONCLUSIONS: Gastric cancer patients over the age of 60 or with a MSI-high status had an increased risk for developing DPM. Further, in stage I gastric cancer, the presence of DPM was associated with a worse prognosis. Therefore, careful pre- and postoperative surveillance is especially important in these patients.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Double primary malignancy; Gastric cancer; Microsatellite instability; Prognosis

Mesh:

Year:  2013        PMID: 24342136     DOI: 10.1016/j.ejso.2013.10.027

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?

Authors:  Hee Jin Kim; Nayoung Kim; Yoon Jin Choi; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Hye Seung Lee; Sang-Hoon Ahn; Do Joong Park; Hyung Ho Kim; Il Tae Son; Sung-Bum Kang; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2015-10-07       Impact factor: 7.370

2.  High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.

Authors:  Karol Polom; Daniele Marrelli; Valeria Pascale; Giandomenico Roviello; Costantino Voglino; Henry Rho; Carla Vindigni; Mario Marini; Raffaele Macchiarelli; Franco Roviello
Journal:  J Cancer Res Clin Oncol       Date:  2016-05-20       Impact factor: 4.553

3.  Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid.

Authors:  Sung Jin Oh; Dong Sik Bae; Byoung Jo Suh
Journal:  Ann Surg Treat Res       Date:  2015-05-14       Impact factor: 1.859

4.  Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms.

Authors:  Young Beak Kim; Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan Sup Shim; Hye Seung Han
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

5.  Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers.

Authors:  Yoon Young Choi; Su-Jin Shin; Jae Eun Lee; Lisa Madlensky; Seung-Tae Lee; Ji Soo Park; Jeong-Hyeon Jo; Hyunki Kim; Daniela Nachmanson; Xiaojun Xu; Sung Hoon Noh; Jae-Ho Cheong; Olivier Harismendy
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

6.  Laparoscopic radical resection of gastric cancer and metachronous colon cancer-a case report.

Authors:  Wenbin Jiang; Qijiang Mao; Xiaoli Wu; Weihua Yu; Dingwei Chen
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

7.  Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer.

Authors:  Ching-Feng Wu; Jui-Ying Fu; Chi-Ju Yeh; Yun-Hen Liu; Ming-Ju Hsieh; Yi-Cheng Wu; Ching-Yang Wu; Ying-Huang Tsai; Wen-Chi Chou
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.